Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Blake Insider Profile

4 Followers

Mark Blake, EVP - Strategy & Corp. Dev. at Cardinal Health, holds 20.41K shares in Cardinal Health (Ticker: CAH). Most recently, Mark Blake Sold 24,668 shares of Cardinal Health on Nov 10, 2014 for an estimated value of $1.96M.

Mark Blake's Trading History

CAH
Cardinal Health
Nov 10, 2014EVP - Strategy & Corp. Dev.Informative Sell1.96M$5.74M
CAH
Insider Shares: 20.41K (<0.01%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 10, 2014Informative Sell$1.96M24,668$79.50-13.20%
Aug 19, 2014Informative Sell$587.38K8,142$72.14-19.40%
Aug 07, 2014Uninformative Buy$0.003,398$0.00―
Jul 28, 2014Uninformative Sell$1.70M23,114$73.41―
May 20, 2014Uninformative Sell$312.75K4,703$66.50―

You May Also Like

Mark Blake insider profile FAQ

What is the percentage of profitable transactions made by Mark Blake?
The percentage of profitable transactions made by Mark Blake is 0%.
What is the average return per transaction made by Mark Blake?
The average return per transaction made by Mark Blake is -19.50%.
What stocks does Mark Blake hold?
Mark Blake holds: CAH stocks.
What was Mark Blake’s latest transaction?
Mark Blake’s latest transaction was an Informative Sell of $1.96M.
What was Mark Blake's most profitable transaction?
Mark Blake’s most profitable transaction was an Informative Sell of CAH stock on November 10, 2014. The return on the trade was -13.20%.
What is Mark Blake's role in Cardinal Health?
Mark Blake's role in Cardinal Health is EVP - Strategy & Corp. Dev..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.